These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35114109)

  • 21. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
    Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
    Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C.
    Petäjä J; Fernández JA; Gruber A; Griffin JH
    J Clin Invest; 1997 Jun; 99(11):2655-63. PubMed ID: 9169495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor Xa activation of factor V is of paramount importance in initiating the coagulation system: lessons from a tick salivary protein.
    Schuijt TJ; Bakhtiari K; Daffre S; Deponte K; Wielders SJ; Marquart JA; Hovius JW; van der Poll T; Fikrig E; Bunce MW; Camire RM; Nicolaes GA; Meijers JC; van 't Veer C
    Circulation; 2013 Jul; 128(3):254-66. PubMed ID: 23817575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent anticoagulant aptamer directed against factor IXa blocks macromolecular substrate interaction.
    Sullenger B; Woodruff R; Monroe DM
    J Biol Chem; 2012 Apr; 287(16):12779-86. PubMed ID: 22334679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The anticoagulant function of coagulation factor V.
    Cramer TJ; Gale AJ
    Thromb Haemost; 2012 Jan; 107(1):15-21. PubMed ID: 22116556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mechanism of inactivation of human factor V and human factor Va by activated protein C.
    Kalafatis M; Rand MD; Mann KG
    J Biol Chem; 1994 Dec; 269(50):31869-80. PubMed ID: 7989361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.
    Jeimy SB; Fuller N; Tasneem S; Segers K; Stafford AR; Weitz JI; Camire RM; Nicolaes GA; Hayward CP
    Thromb Haemost; 2008 Dec; 100(6):1058-67. PubMed ID: 19132231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional properties of recombinant factor V mutated in a potential calcium-binding site.
    Sørensen KW; Nicolaes GA; Villoutreix BO; Yamazaki T; Tans G; Rosing J; Dahlbäck B
    Biochemistry; 2004 May; 43(19):5803-10. PubMed ID: 15134454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation.
    Heeb MJ; Mesters RM; Fernández JA; Hackeng TM; Nakasone RK; Griffin JH
    Thromb Haemost; 2013 Aug; 110(2):275-82. PubMed ID: 23892573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation.
    Ni Ainle F; Preston RJ; Jenkins PV; Nel HJ; Johnson JA; Smith OP; White B; Fallon PG; O'Donnell JS
    Blood; 2009 Aug; 114(8):1658-65. PubMed ID: 19531655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa.
    Evenäs P; García de Frutos P; Nicolaes GA; Dahlbäck B
    Thromb Haemost; 2000 Aug; 84(2):271-7. PubMed ID: 10959700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulant activity of a sulfated galactan: serpin-independent effect and specific interaction with factor Xa.
    Glauser BF; Rezende RM; Melo FR; Pereira MS; Francischetti IM; Monteiro RQ; Rezaie AR; Mourão PA
    Thromb Haemost; 2009 Dec; 102(6):1183-93. PubMed ID: 19967150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural basis of thrombin-mediated factor V activation: the Glu666-Glu672 sequence is critical for processing at the heavy chain-B domain junction.
    Corral-Rodríguez MÁ; Bock PE; Hernández-Carvajal E; Gutiérrez-Gallego R; Fuentes-Prior P
    Blood; 2011 Jun; 117(26):7164-73. PubMed ID: 21555742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RAID3--An interleukin-6 receptor-binding aptamer with post-selective modification-resistant affinity.
    Mittelberger F; Meyer C; Waetzig GH; Zacharias M; Valentini E; Svergun DI; Berg K; Lorenzen I; Grötzinger J; Rose-John S; Hahn U
    RNA Biol; 2015; 12(9):1043-53. PubMed ID: 26383776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membrane-dependent interaction of factor Xa and prothrombin with factor Va in the prothrombinase complex.
    Qureshi SH; Yang L; Manithody C; Rezaie AR
    Biochemistry; 2009 Jun; 48(22):5034-41. PubMed ID: 19378973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidote control of aptamer therapeutics: the road to a safer class of drug agents.
    Bompiani KM; Woodruff RS; Becker RC; Nimjee SM; Sullenger BA
    Curr Pharm Biotechnol; 2012 Aug; 13(10):1924-34. PubMed ID: 22352726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three-dimensional model of coagulation factor Va bound to activated protein C.
    Pellequer JL; Gale AJ; Getzoff ED; Griffin JH
    Thromb Haemost; 2000 Nov; 84(5):849-57. PubMed ID: 11127867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased anticoagulant activity of thrombin-binding DNA aptamers by nanoscale organization on DNA nanostructures.
    Rangnekar A; Zhang AM; Li SS; Bompiani KM; Hansen MN; Gothelf KV; Sullenger BA; LaBean TH
    Nanomedicine; 2012 Jul; 8(5):673-81. PubMed ID: 21889476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel antidote-controlled anticoagulant reduces thrombin generation and inflammation and improves cardiac function in cardiopulmonary bypass surgery.
    Nimjee SM; Keys JR; Pitoc GA; Quick G; Rusconi CP; Sullenger BA
    Mol Ther; 2006 Sep; 14(3):408-15. PubMed ID: 16765093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V.
    Thorelli E; Kaufman RJ; Dahlbäck B
    Blood; 1999 Apr; 93(8):2552-8. PubMed ID: 10194434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.